AXIM BIOTECHNOLOGIES, INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross
AXIM BIOTECHNOLOGIES, INC. (AXIM) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross of 8.30 million shares for the 12-month period ending 2020-12-31, per its 10-K/A filed 2021-04-26.
Discontinued › Shareholders' Equity › Shares Granted or Issued, Share-Based Payment Arrangement › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross · last filed 2021-04-26
- AXIM BIOTECHNOLOGIES, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2020 was 8.30M shares, a 315.00% increase from fiscal 2019.
- AXIM BIOTECHNOLOGIES, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2019 was 2.00M shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 12 month |
|---|---|
| 2020-12-31 | 8.30M shares 10-K/A · filed 2021-04-26 |
| 2019-12-31 | 2.00M shares 10-K/A · filed 2021-04-26 |